Osteoclasts and osteoarthritis: Novel intervention targets and therapeutic potentials during aging
Haojue Wang,Tao Yuan,Yi Wang,Changxing Liu,Dengju Li,Ziqing Li,Shui Sun
DOI: https://doi.org/10.1111/acel.14092
IF: 11.005
2024-01-31
Aging Cell
Abstract:Osteoclast serves as a pivotal mediator and communication hub within the subchondral bone, accelerating the onset and progression of osteoarthritis (OA). Aging‐related alterations (cellular senescence, inflammaging, mitochondrial dysfunction, abnormal histone modification, non‐coding RNAs, DNA methylation, dysregulated autophagy and molecular chaperones) significantly enhance osteoclast activities, thereby contributing to OA pathogenesis. Osteoarthritis (OA), a chronic degenerative joint disease, is highly prevalent among the aging population, and often leads to joint pain, disability, and a diminished quality of life. Although considerable research has been conducted, the precise molecular mechanisms propelling OA pathogenesis continue to be elusive, thereby impeding the development of effective therapeutics. Notably, recent studies have revealed subchondral bone lesions precede cartilage degeneration in the early stage of OA. This development is marked by escalated osteoclast‐mediated bone resorption, subsequent imbalances in bone metabolism, accelerated bone turnover, and a decrease in bone volume, thereby contributing significantly to the pathological changes. While the role of aging hallmarks in OA has been extensively elucidated from the perspective of chondrocytes, their connection with osteoclasts is not yet fully understood. There is compelling evidence to suggest that age‐related abnormalities such as epigenetic alterations, proteostasis network disruption, cellular senescence, and mitochondrial dysfunction, can stimulate osteoclast activity. This review intends to systematically discuss how aging hallmarks contribute to OA pathogenesis, placing particular emphasis on the age‐induced shifts in osteoclast activity. It also aims to stimulate future studies probing into the pathological mechanisms and therapeutic approaches targeting osteoclasts in OA during aging.
cell biology,geriatrics & gerontology